Skip to content

Enliven Therapeutics

US · ELVN #2416 by market cap Listed 1970
46.53 +0.12 +0.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 10 analysts

Buy
Avg price target 74.88 +60.9%
Price target rangecurrent 46.53
Low70.00
Avg74.88
High82.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 H.C. Wainwright -- Buy 73.00
2026-11-06 JonesTrading -- Buy 70.00
2026-11-06 Guggenheim -- Buy 78.00
2026-11-05 Stifel -- Buy 82.00
2026-11-05 Barclays -- Buy 78.00
2026-10-19 H.C. Wainwright -- Buy 73.00
2026-10-07 TD Cowen -- Buy --
2026-10-07 Barclays -- Buy 78.00
2026-10-06 William Blair -- Buy --
2026-10-05 Morgan Stanley -- Buy 70.00
2026-10-02 Morgan Stanley -- Buy 70.00
2026-10-01 J.P. Morgan -- Buy 75.00
2026-08-22 William Blair -- Buy --
2026-08-18 William Blair -- Buy --
2026-08-18 Barclays -- Buy 78.00
2026-08-17 Mizuho Securities -- Buy 73.00
2026-08-13 Stifel -- Buy 82.00
2026-08-08 LifeSci Capital -- Buy 70.00
2026-08-07 LifeSci Capital -- Buy 70.00
2026-08-06 JonesTrading -- Buy 70.00
2026-08-06 Baird -- Buy 75.00
2026-08-06 Clear Street -- Buy 68.00
2026-08-06 Stifel -- Buy 82.00
2026-08-05 TD Cowen -- Buy --
2026-08-05 Goldman Sachs -- Buy 80.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Enliven Therapeutics discussion 0 comments

Add a comment